Cyclophosphamide Injection
Product Images NDC 55150-271

5 FDA label images from Eugia Us Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 55150-271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel- 500 mg Per 2.5 mL (200 mg Per mL) (Container Label)

Package Label-principal Display Panel- 500 mg Per 2.5 mL (200 mg Per mL) (Container Label)
Cyclophosphamide Injection 500 mg per 2.5 mL (200 mg per mL) single-dose vial label. The label specifies intravenous use after dilution and indicates the product as a hazardous agent. Distributed by AuroMedics Pharma LLC, manufactured in India, with storage instructions at 2°C to 8°C (36°F to 46°F).*
FDA Label Image

Package Label-principal Display Panel-500 mg Per 2.5 mL (200 mg Per mL) (Container-Carton (1 Vial))

Package Label-principal Display Panel-500 mg Per 2.5 mL (200 mg Per mL) (Container-Carton (1 Vial))
Cyclophosphamide Injection 500 mg per 2.5 mL (200 mg per mL) packaging label. The label indicates it is a hazardous agent for intravenous infusion after dilution, single-dose vial. It lists cyclophosphamide content per mL and storage instructions at 2°C to 8°C. Labeler/distributor information includes Auromedics Pharma LLC and Eugia US LLC.*
FDA Label Image

Package Label-principal Display Panel- 1 G Per 5 mL (200 mg Per mL) (Container Label)

Package Label-principal Display Panel- 1 G Per 5 mL (200 mg Per mL) (Container Label)
Cyclophosphamide Injection 1 g per 5 mL (200 mg per mL) single-dose vial label. The label indicates intravenous infusion use after dilution. It is marked as a hazardous agent and sterile, nonpyrogenic. Distributed by AuroMedics Pharma LLC, made in India, with storage instructions to refrigerate at 2°C to 8°C. Contains Cyclophosphamide 200 mg and citric acid per mL.*
FDA Label Image

Package Label-principal Display Panel-1 G Per 5 mL (200 mg Per mL) (Container-Carton (1 Vial))

Package Label-principal Display Panel-1 G Per 5 mL (200 mg Per mL) (Container-Carton (1 Vial))
Cyclophosphamide Injection 1 g per 5 mL (200 mg per mL) vial packaging label. The label states administration by intravenous infusion after dilution, contains hazardous agent warnings, storage instructions to refrigerate at 2°C to 8°C, and notes the vial is single-dose. Distributed by AuroMedics Pharma LLC, made in India, with the NDC 55150-271-01.*
FDA Label Image

Cyclophosphamide-structure (Cyclophosphamide Str)

Cyclophosphamide-structure (Cyclophosphamide Str)
Chemical structure of Cyclophosphamide, depicted as a nitrogen mustard compound with a phosphoramide moiety and associated water molecule (H2O). The structure includes a six-membered ring with phosphorus and oxygen atoms, illustrating the molecular configuration of the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.